Publication:
Late presentation for HIV remains a major health issue in Spain: Results from a multicenter cohort study, 2004-2018.

dc.contributor.authorRava, Marta
dc.contributor.authorDomínguez-Domínguez, Lourdes
dc.contributor.authorBisbal, Otilia
dc.contributor.authorLópez-Cortés, Luis Fernando
dc.contributor.authorBusca, Carmen
dc.contributor.authorAntela, Antonio
dc.contributor.authorGonzález-Ruano, Patricia
dc.contributor.authorHernández, Cristina
dc.contributor.authorIribarren, Josè-Antonio
dc.contributor.authorRubio, Rafael
dc.contributor.authorMoreno, Santiago
dc.contributor.authorJarrín, Inmaculada
dc.contributor.authorCohort of the Spanish HIV/AIDS Research Network (CoRIS)
dc.date.accessioned2023-02-09T11:37:42Z
dc.date.available2023-02-09T11:37:42Z
dc.date.issued2021-04-21
dc.description.abstractWith the purpose of reducing the well-known negative impact of late presentation (LP) on people living with HIV (PLWH), guidelines on early HIV diagnosis were published in 2014 in Spain, but since then no data on LP prevalence have been published. To estimate prevalence and risk factors of LP and to evaluate their impact on the development of clinical outcomes in the Cohort of the Spanish HIV/AIDS Research Network (CoRIS) during 2004-2018. CoRIS is an open prospective multicenter cohort of PLWH, adults, naive to ART at entry. LP was defined as HIV diagnosis with CD4 count ≤350 cells/μL or an AIDS defining event (ADE). Multivariable Poisson regression models were used to estimate both prevalence ratios (PR) for the association of potential risk factors with LP and Incidence rate ratios (IRRs) for its impact on the development of the composite endpoint (first ADE, first serious non-AIDS event [SNAE] or overall mortality). 14,876 individuals were included. Overall, LP prevalence in 2004-2018 was 44.6%. Risk factors for LP included older age, having been infected through injection drug use or heterosexual intercourse, low educational level and originating from non-European countries. LP was associated with an increased risk of the composite endpoint (IRR: 1.34; 95%CI 1.20, 1.50), ADE (1.39; 1.18, 1.64), SNAE (1.22; 1.01, 1.47) and mortality (1.71; 1.41, 2.08). LP remains a health problem in Spain, mainly among certain populations, and is associated with greater morbidity and mortality. Public policies should be implemented to expand screening and early diagnosis of HIV infection, for a focus on those at greatest risk of LP.
dc.identifier.doi10.1371/journal.pone.0249864
dc.identifier.essn1932-6203
dc.identifier.pmcPMC8059864
dc.identifier.pmid33882093
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059864/pdf
dc.identifier.unpaywallURLhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0249864&type=printable
dc.identifier.urihttp://hdl.handle.net/10668/17613
dc.issue.number4
dc.journal.titlePloS one
dc.journal.titleabbreviationPLoS One
dc.language.isoen
dc.organizationHospital Universitario Virgen del Rocío
dc.page.numbere0249864
dc.pubmedtypeJournal Article
dc.pubmedtypeResearch Support, Non-U.S. Gov't
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subject.meshAdult
dc.subject.meshAnti-Retroviral Agents
dc.subject.meshCD4 Lymphocyte Count
dc.subject.meshCohort Studies
dc.subject.meshDelayed Diagnosis
dc.subject.meshEducational Status
dc.subject.meshFemale
dc.subject.meshHIV Infections
dc.subject.meshHumans
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.subject.meshPrevalence
dc.subject.meshProspective Studies
dc.subject.meshRisk Factors
dc.subject.meshSpain
dc.subject.meshSubstance Abuse, Intravenous
dc.subject.meshSurvival Rate
dc.titleLate presentation for HIV remains a major health issue in Spain: Results from a multicenter cohort study, 2004-2018.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number16
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMC8059864.pdf
Size:
919.22 KB
Format:
Adobe Portable Document Format